These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 19802919)
1. Renal and retinal effects of enalapril and losartan in type 1 diabetes. Katavetin P; Katavetin P N Engl J Med; 2009 Oct; 361(14):1410-1; author reply 1411. PubMed ID: 19802919 [No Abstract] [Full Text] [Related]
2. Renal and retinal effects of enalapril and losartan in type 1 diabetes. Tamsma JT N Engl J Med; 2009 Oct; 361(14):1410; author reply 1411. PubMed ID: 19797291 [No Abstract] [Full Text] [Related]
3. Diabetes complications and the renin-angiotensin system. Perkins BA; Aiello LP; Krolewski AS N Engl J Med; 2009 Jul; 361(1):83-5. PubMed ID: 19571288 [No Abstract] [Full Text] [Related]
4. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney. Bilous R Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685 [No Abstract] [Full Text] [Related]
5. Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy. Cardiovasc J Afr; 2009; 20(4):265. PubMed ID: 19701543 [No Abstract] [Full Text] [Related]
6. Renal and retinal effects of enalapril and losartan in type 1 diabetes. Mauer M; Zinman B; Gardiner R; Suissa S; Sinaiko A; Strand T; Drummond K; Donnelly S; Goodyer P; Gubler MC; Klein R N Engl J Med; 2009 Jul; 361(1):40-51. PubMed ID: 19571282 [TBL] [Abstract][Full Text] [Related]
7. Treating diabetic nephropathy: unfinished success is not failure. Lewis J Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442 [No Abstract] [Full Text] [Related]
8. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Klein R; Moss SE; Sinaiko AR; Zinman B; Gardiner R; Suissa S; Donnelly SM; Kramer MS; Goodyer P; Strand T; Mauer M Ophthalmology; 2006 Dec; 113(12):2231-6. PubMed ID: 16996597 [TBL] [Abstract][Full Text] [Related]
9. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Sjølie AK; Dodson P; Hobbs FR Int J Clin Pract; 2011 Feb; 65(2):148-53. PubMed ID: 21235695 [TBL] [Abstract][Full Text] [Related]
10. The Renin-Angiotensin system and vascular disease in diabetes. Deinum J; Chaturvedi N Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606 [TBL] [Abstract][Full Text] [Related]
11. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]
12. Kidney disease in diabetology: lessons from 2008. Schernthaner G Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896 [No Abstract] [Full Text] [Related]
13. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction? Rossing P; Parving HH; de Zeeuw D Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724 [No Abstract] [Full Text] [Related]
14. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be? Hollenberg NK; Epstein M Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325 [No Abstract] [Full Text] [Related]
15. The renin-angiotensin system and diabetic nephropathy. Gurley SB; Coffman TM Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683 [TBL] [Abstract][Full Text] [Related]
16. Prospects for angiotensin receptor blockers in diabetic retinopathy. Sjølie AK Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627 [TBL] [Abstract][Full Text] [Related]